Eli Lilly has issued a warning regarding the shortage of an insulin product in both Canada and the U.S. that is expected to persist until mid-April. Read this story
Eli Lilly has issued a warning regarding the shortage of an insulin product in both Canada and the U.S. that is expected to persist until mid-April. Read this story
More from Global News | Diabetes Humalog Type 1 diabetes Canada Health